drugset
drugset / Trial / NCT06798675

Phase 2a Study for PK/PD of nC-001

NCT06798675 ↗

Phase 2 Not yet recruiting 24 enrolled nephCentric
RandomizedParallel-groupTriple-blindTreatment

Summary

CHRONIC EUVOLEMIC HYPONATREMIA

Timeline

Start
2025-08
Primary completion
2026-03
Completion
2026-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator nC-001 Unknown 15 g —
Comparator nC-001 Unknown 30 g —

Indications

No indication recorded.